- Home
- AXP vs MRK Comparison
AXP vs MRK Comparison
Compare AXP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXP
- MRK
- Stock Information
- Founded
- AXP 1850
- MRK 2000
- Country
- AXP United States
- MRK United States
- Employees
- AXP N/A
- MRK N/A
- Industry
- AXP Finance: Consumer Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- AXP Finance
- MRK Health Care
- Exchange
- AXP Nasdaq
- MRK Nasdaq
- Market Cap
- AXP 218.5B
- MRK 218.2B
- IPO Year
- AXP N/A
- MRK N/A
- Fundamental
- Price
- AXP $283.67
- MRK $77.66
- Analyst Decision
- AXP Hold
- MRK Buy
- Analyst Count
- AXP 21
- MRK 15
- Target Price
- AXP $292.60
- MRK $115.93
- AVG Volume (30 Days)
- AXP 3.1M
- MRK 15.6M
- Earning Date
- AXP 04-17-2025
- MRK 04-24-2025
- Dividend Yield
- AXP 1.16%
- MRK 4.17%
- EPS Growth
- AXP 17.98
- MRK 667.14
- EPS
- AXP 14.32
- MRK 6.88
- Revenue
- AXP $62,049,000,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- AXP $18.59
- MRK $2.31
- Revenue Next Year
- AXP $8.09
- MRK $6.35
- P/E Ratio
- AXP $19.81
- MRK $11.29
- Revenue Growth
- AXP 9.05
- MRK 4.10
- 52 Week Low
- AXP $220.43
- MRK $75.93
- 52 Week High
- AXP $326.27
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- AXP 62.86
- MRK 36.06
- Support Level
- AXP $273.61
- MRK $78.29
- Resistance Level
- AXP $281.59
- MRK $84.71
- Average True Range (ATR)
- AXP 7.13
- MRK 2.30
- MACD
- AXP 3.13
- MRK 0.08
- Stochastic Oscillator
- AXP 96.04
- MRK 16.63
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. Since 2018, it has operated in three segments: global consumer services, global commercial services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.